AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
ACB   14.30 (-1.58%)
F   6.19 (+4.92%)
GILD   74.40 (+1.56%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BAC   25.99 (+4.63%)
BA   173.16 (+12.95%)
Log in

NASDAQ:ARMPAmpliPhi Biosciences Stock Price, Forecast & News

$3.69
-0.06 (-1.60 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.58
Now: $3.69
$3.73
50-Day Range
$2.99
MA: $3.29
$4.05
52-Week Range
$2.45
Now: $3.69
$6.92
Volume5,069 shs
Average Volume134,680 shs
Market Capitalization$40.32 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ARMP
CUSIPN/A
CIKN/A
Phone310-655-2928

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees33
Market Cap$40.32 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive ARMP News and Ratings via Email

Sign-up to receive the latest news and ratings for ARMP and its competitors with MarketBeat's FREE daily newsletter.

AmpliPhi Biosciences (NASDAQ:ARMP) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of AmpliPhi Biosciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmpliPhi Biosciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AmpliPhi Biosciences.

When is AmpliPhi Biosciences' next earnings date?

AmpliPhi Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for AmpliPhi Biosciences.

How were AmpliPhi Biosciences' earnings last quarter?

AmpliPhi Biosciences Corporation (NASDAQ:ARMP) announced its quarterly earnings data on Thursday, March, 19th. The company reported ($0.48) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.76) by $0.28. View AmpliPhi Biosciences' earnings history.

Has AmpliPhi Biosciences been receiving favorable news coverage?

News coverage about ARMP stock has been trending very negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AmpliPhi Biosciences earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutAmpliPhi Biosciences.

Who are some of AmpliPhi Biosciences' key competitors?

What other stocks do shareholders of AmpliPhi Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmpliPhi Biosciences investors own include Callon Petroleum (CPE), Himax Technologies (HIMX), Remark (MARK), Microvision (MVIS), Ritter Pharmaceuticals (RTTR), CytoDyn (CYDY), Opko Health (OPK), Vuzix (VUZI), Audioeye (AEYE) and Bank of America (BAC).

Who are AmpliPhi Biosciences' key executives?

AmpliPhi Biosciences' management team includes the following people:
  • Mr. Todd R. Patrick, CEO & Director (Age 57)
  • Dr. Brian Varnum, Pres & Chief Devel. Officer
  • Dr. Wenyuan Shi, Co-Founder & Founding Scientist
  • Mr. Steven R. Martin, Chief Financial Officer (Age 59)
  • Mr. Duane Alfred Morris, VP of Operations (Age 70)

What is AmpliPhi Biosciences' stock symbol?

AmpliPhi Biosciences trades on the NASDAQ under the ticker symbol "ARMP."

How do I buy shares of AmpliPhi Biosciences?

Shares of ARMP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AmpliPhi Biosciences' stock price today?

One share of ARMP stock can currently be purchased for approximately $3.69.

How big of a company is AmpliPhi Biosciences?

AmpliPhi Biosciences has a market capitalization of $40.32 million. AmpliPhi Biosciences employs 33 workers across the globe.

What is AmpliPhi Biosciences' official website?

The official website for AmpliPhi Biosciences is www.armatapharma.com.

How can I contact AmpliPhi Biosciences?

The company can be reached via phone at 310-655-2928.

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.